scholarly journals Mycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients

2014 ◽  
Vol 20 (1) ◽  
pp. 59-64 ◽  
Author(s):  
M.A.M. Morgado de Abreu ◽  
A.M. Roselino ◽  
M. Enokihara ◽  
S. Nonogaki ◽  
L.E. Prestes-Carneiro ◽  
...  
Keyword(s):  
Oral Mucosa ◽  
Mycobacterium Leprae ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

Analysis of the Myeloid-Derived Suppressor Cells and Annexin A1 in Multibacillary Leprosy and Reactional Episodes

2020 ◽  
Author(s):  
Amilcar Sabino Damazo ◽  
Stephanni Figueiredo da Silva ◽  
Leticia Rossetto da Silva Cavalcante ◽  
Ezequiel Angelo Fonseca Junior ◽  
Joselina Maria da Silva ◽  
...  
Keyword(s):  
Suppressor Cells ◽  
Suppressor Cell ◽  
Mycobacterium Leprae ◽  
Histopathological Analysis ◽  
Annexin A1 ◽  
Myeloid Derived Suppressor Cells ◽  
Myeloid Derived Suppressor Cell ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

Abstract Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Patients have distinct clinical forms, and host´s immunological response regulate those manifestations. In this work, the presence of the myeloid-derived suppressor cell and the regulatory protein annexin A1 is described in patients with multibacillary leprosy and with type 1 and 2 reactions. Methods: Patients were submitted to skin biopsy for histopathological analysis to obtain bacilloscopic index. Immunofluorescence was used to detect myeloid-derived suppressor cells and annexin A1.Results: The data demonstrated that the presence of granulocytic and monocytic myeloid-derived suppressor cells in leprosy patients. The high number of monocytic myeloid-derived suppressor cells were observed in lepromatous leprosy and type 2 reactional patients with Bacillus Calmette–Guérin (BCG) vaccination scar. The presence of annexin A1 was observed in all myeloid-derived suppressor cells. In particularly, the monocytic myeloid-derived suppressor cell in the lepromatous patients has higher levels of this protein when compared to the reactional patients. This data suggest that the higher expression of this protein may be related to regulatory response against a severe infection, contributing to anergic response. In type 1 reactional patients, the expression of annexin A1 was reduced. Conclusions: Myeloid-derived suppressor cell are present in leprosy patients and annexin A1 might be regulated the host response against Mycobacterium leprae.

scholarly journals Powerful Bactericidal Activity of Moxifloxacin in Human Leprosy

2008 ◽  
Vol 52 (9) ◽  
pp. 3113-3117 ◽  
Author(s):  
Fe Eleanor F. Pardillo ◽  
Jasmin Burgos ◽  
Tranquilino T. Fajardo ◽  
Eduardo Dela Cruz ◽  
Rodolfo M. Abalos ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Side Effects ◽  
Bactericidal Activity ◽  
Mycobacterium Leprae ◽  
Skin Lesions ◽  
Definite Improvement ◽  
Highly Effective ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

ABSTRACT In a clinical trial of moxifloxacin in eight multibacillary leprosy patients, moxifloxacin proved highly effective. In all trial patients, a single 400-mg dose of moxifloxacin resulted in significant killing (P ≤ 0.006) of Mycobacterium leprae, ranging from 82% to 99%, with a mean of 91%. In all instances, no viable bacilli were detected with an additional 3 weeks of daily therapy, this observed rapid bactericidal activity being matched previously only by rifampin. On moxifloxacin therapy, skin lesions cleared exceedingly rapidly with definite improvement observed consistently after eight doses and progressive resolution continuing for the 56 days of the trial. Side effects, toxicities, and laboratory abnormalities were mild, not requiring discontinuation of therapy.

scholarly journals Clinical profile and deformities in leprosy patients: a record based study

2020 ◽  
Vol 6 (2) ◽  
pp. 156
Author(s):  
Anita Sanker ◽  
Sandhya George ◽  
Sindhu Chunangat Bhaskaramenon
Keyword(s):  
Public Health Problem ◽  
Mycobacterium Leprae ◽  
Clinical Profile ◽  
Current Status ◽  
Age Group ◽  
Medical College ◽  
Tribal Area ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

<p class="abstract"><strong>Background:</strong> Leprosy is a chronic disease caused by <em>Mycobacterium leprae</em>, infectious in some cases, and affecting the peripheral nervous system, skin and certain other tissues. Even though leprosy was declared eliminated as a public health problem in India on December 2005, new cases of leprosy continue to appear. Hence a study on clinical profile and deformities in all leprosy cases registered in the last 5 years was done to know the current status of leprosy in this area.</p><p class="abstract"><strong>Methods: </strong>This was a retrospective record-based study of leprosy cases done at Government Medical College, Manjeri, for a period of 5 years from October 2014 to September 2019.<strong></strong></p><p class="abstract"><strong>Results:</strong> 42 cases from the record were included in the study. Maximum cases belonged to the age group of 31 to 40 and males were more than females. 81% of the patients were multibacillary leprosy (MB) and 8 cases belonged to paucibacillary (PB) leprosy. Four child cases were registered as PB cases. Mostly encountered clinical diagnosis was borderline tuberculoid leprosy (23 out of 42) and two had type 1 reaction. Seven patients had deformity of which two had grade 2 deformity and rest had grade 1 deformity.</p><p><strong>Conclusions:</strong> One patient who presented with grade 2 deformity and type 1 reaction was from tribal area indicating low awareness about leprosy among them. More number of cases in the multibacillary group and presence of child cases and deformities reinforces the need for strict surveillance to eradicate leprosy. </p>

scholarly journals Analysis of the myeloid-derived suppressor cells and annexin A1 in multibacillary leprosy and reactional episodes

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Stephanni Figueiredo da Silva ◽  
Leticia Rossetto da Silva Cavalcante ◽  
Ezequiel Angelo Fonseca Junior ◽  
Joselina Maria da Silva ◽  
José Cabral Lopes ◽  
...  
Keyword(s):  
Suppressor Cells ◽  
Suppressor Cell ◽  
Mycobacterium Leprae ◽  
Histopathological Analysis ◽  
Annexin A1 ◽  
Myeloid Derived Suppressor Cells ◽  
Myeloid Derived Suppressor Cell ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

Abstract Background Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Patients have distinct clinical forms, and the host´s immunological response regulate those manifestations. In this work, the presence of the myeloid-derived suppressor cell and the regulatory protein annexin A1 is described in patients with multibacillary leprosy and with type 1 and 2 reactions. Methods Patients were submitted to skin biopsy for histopathological analysis to obtain a bacilloscopic index. Immunofluorescence was used to detect myeloid-derived suppressor cells and annexin A1. Results The data demonstrated that the presence of granulocytic and monocytic myeloid-derived suppressor cells in leprosy patients. A high number of monocytic myeloid-derived suppressor cells were observed in lepromatous leprosy and type 2 reactional patients. The presence of annexin A1 was observed in all myeloid-derived suppressor cells. In particular, the monocytic myeloid-derived suppressor cell in the lepromatous patients has higher levels of this protein when compared to the reactional patients. This data suggest that the higher expression of this protein may be related to regulatory response against a severe infection, contributing to anergic response. In type 1 reactional patients, the expression of annexin A1 was reduced. Conclusions Myeloid-derived suppressor cell are present in leprosy patients and annexin A1 might be regulated the host response against Mycobacterium leprae.

The Response to Chemotherapy of Serum Mycobacterium Leprae-Specific Antigen in Multibacillary Leprosy Patients

1991 ◽  
Vol 44 (6) ◽  
pp. 702-708 ◽  
Author(s):  
Paul W. Roche ◽  
Kapil Dev Neupane ◽  
Wim J. Theuvenet ◽  
Sang-Nae Cho ◽  
Warwick J. Britton ◽  
...  
Keyword(s):  
Specific Antigen ◽  
Mycobacterium Leprae ◽  
Response To Chemotherapy ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

scholarly journals Postgenomic Approach To Identify Novel Mycobacterium leprae Antigens with Potential To Improve Immunodiagnosis of Infection

2005 ◽  
Vol 73 (9) ◽  
pp. 5636-5644 ◽  
Author(s):  
Annemieke Geluk ◽  
Michèl R. Klein ◽  
Kees L. M. C. Franken ◽  
Krista E. van Meijgaarden ◽  
Brigitte Wieles ◽  
...  
Keyword(s):  
Mrna Level ◽  
Mycobacterium Leprae ◽  
Immunoglobulin M ◽  
Diagnostic Tools ◽  
Comparative Genomic ◽  
Healthy Controls ◽  
Mycobacterial Genome ◽  
Genomic Analyses ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

ABSTRACT Early detection of Mycobacterium leprae infection is considered an important component of strategies aiming at reducing transmission of infection, but currently available diagnostic tools often lack sufficient sensitivity and specificity to reach this goal. Recent comparative genomics have revealed the presence of 165 M. leprae genes with no homologue in M. tuberculosis. We selected 17 of these genes for further study. All 17 genes were found to be expressed at the mRNA level in M. leprae from infected mice and from a multibacillary leprosy patient. Additional comparative genomic analyses of all currently available mycobacterial genome databases confirmed 12 candidate genes to be unique to M. leprae, whereas 5 genes had homologues in mycobacteria other than M. tuberculosis. Evaluation of the immunogenicity of all 17 recombinant proteins in PBMC from 127 Brazilians showed that five antigens (ML0576, ML1989, ML1990, ML2283, and ML2567) induced significant gamma interferon levels in paucibacillary leprosy patients, reactional leprosy patients, and exposed healthy controls but not in most multibacillary leprosy patients, tuberculosis patients, or endemic controls. Importantly, among exposed healthy controls 71% had no detectable immunoglobulin M antibodies to the M. leprae-specific PGL-I but responded to one or more M. leprae antigen(s). Collectively, the M. leprae proteins identified are expressed at the transcriptome level and can efficiently activate T cells of M. leprae-exposed individuals. These proteins may provide new tools to develop tests for specific diagnosis of M. leprae infection and may enhance our understanding of leprosy and its transmission.

scholarly journals Mycobacterium leprae deoxyribonucleic acid positivity on skin lesion of untreated leprosy patients and its route to the skin surface

2019 ◽  
Author(s):  
Endi Novianto ◽  
Patricsia Manalu ◽  
Benny Effendi Wiryadi ◽  
Sri Linuwih Menaldi
Keyword(s):  
Skin Lesion ◽  
Deoxyribonucleic Acid ◽  
Mycobacterium Leprae ◽  
Skin Surface ◽  
Sweat Glands ◽  
Pilosebaceous Unit ◽  
Positive Proportion ◽  
Route Of Transmission ◽  
Leprosy Patients ◽  
Multibacillary Leprosy

The route of transmission of leprosy is still unclear. Multiple opinions exist regarding the environmental dissemination of Mycobacterium leprae (M. leprae). This research aims to identify the positive proportion of M. leprae deoxyribonucleic acid (DNA) on skin lesion surface of untreated multibacillary leprosy patients by polymerase chain reaction (PCR), and its association with the examination result of acid-fast bacilli (AFB) in epidermis, pilosebaceous unit, and sweat glands. The M. leprae DNA sample was taken from smears of the skin lesion surface by using PCR and the skin biopsy test was done to detect AFB in epidermis, pilosebaceous unit, and sweat glands. From 28 subjects, there was 82.1% positive proportion of M. leprae DNA on the skin lesion surface of untreated multibacillary leprosy patients, where all were found in the lepromatous leprosy and borderline leprosy type. The result of AFB was positive in epidermis (71.4%), pilosebaceous unit (46.4%) and sweat glands (53.6%). We found M. leprae by using PCR technique on skin lesion surface of untreated multibacillary leprosy patients, and its route which most likely was through the epidermis.

Sign in / Sign up

Export Citation Format

Share Document